Physician profile
Michael Dann
NPI 1982694725
$12,057.85
in general payments reported to CMS, 2019-2025
35 companies · $3,550 in 2025
The $3,550 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.45 · 2020: $773 · 2021: $1,240 · 2022: $2,255 · 2023: $2,139 · 2024: $2,045 · 2025: $3,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,733.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,704.31 | 2020-2025 | Skyrizi, Rinvoq, Viberzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,504.07 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $861.14 | 2021-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $653.94 | 2019-2025 | Entyvio |
| Pfizer INC. | $651.79 | 2020-2025 | |
| Qol Medical, LLC | $549.90 | 2021-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $381.52 | 2023-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $368.66 | 2022-2025 | Dupixent |
| Celgene Corporation | $364.16 | 2021-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $261.56 | 2024-2025 | Voquezna |
| Ethicon US, LLC | $249.09 | 2021-2022 | |
| Genzyme Corporation | $173.87 | 2023-2025 | |
| Braintree Laboratories, INC. | $151.65 | 2020-2022 | |
| Redhill Biopharma INC. | $136.98 | 2020-2024 | Talicia, Aemcolo, Movantik |
| E.R. Squibb & Sons, L.L.C. | $122.85 | 2023 | Zeposia |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $112.66 | 2025 | Rezdiffra |
| Medtronic, INC. | $103.03 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.16 | 2023-2024 | Cyltezo |
| Viiv Healthcare Company | $57.60 | 2022-2025 | Apretude |
| Phadia US INC. | $54.92 | 2021-2023 | Immunocap |
| Ironwood Pharmaceuticals, INC | $51.30 | 2023-2024 | Linzess |
| Shield Therapeutics INC | $47.54 | 2024 | |
| Nestle Healthcare Nutrition INC. | $45.14 | 2021 | |
| Aimmune Therapeutics, INC. | $44.07 | 2025 | Zenpep |
| Gilead Sciences, INC. | $42.75 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $42.18 | 2022 | |
| Mayne Pharma Commercial LLC | $42.06 | 2025 | |
| Lilly USA, LLC | $41.25 | 2023-2025 | Omvoh |
| Amgen INC. | $33.82 | 2020 | |
| Evoke Pharma, INC. | $24.77 | 2025 | |
| Ucb, INC. | $23.17 | 2021 | |
| Daiichi Sankyo INC. | $21.39 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $16.40 | 2025 | Iqirvo |
| Shire North American Group INC | $15.04 | 2019 | |
| Currax Pharmaceuticals LLC | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.